Reactive skin decon

Ended Purchase Order Awarded

Contract number
SPE2DP21P0676
Awardee
Awarding agency
Obligated
$123,191

Award facts

Opportunity
Contract value 100% obligated
$123,191.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed price purchase order contract to Emergent BioSolutions Canada Inc., a for-profit medical countermeasures provider, for $123,191.00 to supply Reactive Skin Decon lotion. The contract was awarded on June 3, 2021 with a completion date of October 7, 2021. This is a direct contract award, with no set-aside designation. Emergent BioSolutions has received over $770 million in federal contracts from agencies like DLA and the Department of Health and Human Services to provide medical products such as skin decontamination lotion, botulism antitoxin, and vaccinia immune globulin.

Quick answers

Who was awarded contract SPE2DP21P0676?

SPE2DP21P0676 was awarded to Emergent Biosolutions Canada Inc. by Medical Supply Chain (Troop Support) on June 3, 2021.

How much is contract SPE2DP21P0676 worth?

The government has obligated $123,191 on SPE2DP21P0676.

Was contract SPE2DP21P0676 competed?

The extent of competition for SPE2DP21P0676 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award